Using WES and WTS, we demonstrated an increase in mutations in TP53, RB1, NOTCH1, KMTD2, and KMT2C, and an upregulation of MAPK Pathway Activity Score, NK cell infiltration, and the immune checkpoint gene CD276 in VN-MCC tumors. The gene discussed is TP53; the disease is Merkel cell skin cancer.